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Summary  
Various immune responses have been influenced by probiotics and these 
immunomodulatory effects have been proposed for several potential 
applications such as the prevention of infectious diarrhoea, alleviation of 
hypersensitivity reactions and tumour suppression. The new probiotic product 
from LURA d. d., low fat fresh cheese "BioAktiv LGG", contains well-known 
probiotic strain Lactobacillus rhamnosus GG (LGG). The viable count of L. 
rhamnosus GG remained stable and has been 1.3x108 CFU/g of low fat fresh 
cheese "BioAktiv LGG" during storage of 16 days at 4 0C. The effect of L. 
rhamnosus GG from this product on the immune response, as an important 
point in relation to immunomodulation, and its survival/residence time in the 
gastrointestinal tract in Swiss albino mice was also studied. During the 
feeding of mice with L. rhamnosus GG, with a daily dose of 2.2x1010 cells, the 
number of lactobacilli in faeces was increased and reduction of enterobacteria 
and sulphite-reducing clostridia was observed. The similar results were 
obtained in homogenates of large intestine of mice in the 1st and in the 14th 
day after feeding with L. rhamnosus GG, which pointed out the adherence 
ability of examined strain. Furthermore, the oral immunization of Swiss albino 
mice was performed with a dose of 2.2x1010 L. rhamnosus GG cells per day, 
for eight consecutive days. The blood samples were collected on the 4th, 8th, 
10th, 14th and 21st day after the 1st immunization. The sera of mice were tested 
for total and specific anti-lactobacilli IgA, IgG and IgM antibodies by ELISA 
assay. L. rhamnosus GG slightly stimulated the total humoral immune 
response but didn't evoke reaction against itself, which confirms its probiotic 
properties and make new probiotic product, low fat fresh cheese "BioAktiv 
LGG", as good carrier for this probiotic strain. 
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Probiotic-containing products come in a variety of formats: conventional 
foods (probiotic-containing yoghurts, fluid milk and cheese, consumed 
primarily for nutritional purpose, but also for probiotic benefits), food 
supplements or fermented milks (food formulations whose primary purpose is 
a delivery vehicle for probiotic bacteria and their fermentation end products, 
consumed for health effects, in monoculture or mixed culture, and dietary 
supplements (capsules and other formats designed to be taken by healthy 
individuals looking to enhance health) (Sanders and Huis in't Veld, 1999). 
Only a few studies have been published about probiotics in cheese. However, 
high levels of fat or salt have not been considered in the development of 
probiotic cheeses (Ryhänen et al. 2001). The LURA d.d. developed a new 
type of low fat fresh cheese "BioAktiv LGG" with Lactobacillus rhamnosus 
GG (LGG) which is claimed to have probiotic properties. Probiotics have been 
reported to have several healthy benefits such as balancing of intestinal 
microflora, stimulation of the immune system, prevention of diarrhoea and 
anticarcinogenic activity (Šušković  et al. 2001).  
When pathogenic bacteria and viruses invade the body from the exterior, 
the body has the capability to recognize these as foreign substances and act to 
remove them. This capability is generally termed the "immune system", which 
includes the humoral and the cellular immune systems. Lactic acid bacteria 
and its components can act on the immune system within the body, and in 
many cases enhance the immune response (Yasui et al. 1999). The aim of this 
work was to determine the viable count of L. rhamnosus GG (LGG), in low fat 
fresh cheese "BioAktiv LGG" from LURA d.d. during storage, survival and 
adhesion of this strain in the gastrointestinal tract of mice and to assess its 
immunomodulatory effect. 
 
Materials and Methods 
Determination of the viable count of L. rhamnosus GG during storage 
To assess the viability of L. rhamnosus GG in "BioAktiv LGG" low fat 
fresh cheese, during refrigerated storage, with appropriate dilutions from 
cheese were prepared and spread on MRS agar plates containing vancomycin. 
The plates were incubated for 48 h at 37  oC. 
 







Determination of the viable count of  L. rhamnosus GG during the transit 
trough gastrointestinal (GI) tract of mice 
Survival of L. rhamnosus GG during transit trough GI tract of mice was 
determined in faeces samples. Fresh faecal samples were taken from single 
Swiss albino mice, which had been isolated in plastic cages. The mice had 
been fed by probiotic strain L. rhamnosus GG with a dose of 2.2ּ1010 of viable 
bacterial cells. Each faecal sample was used to determine faecal microflora. 
Samples of approximately 1 g (wet weight) were suspended in 1 mL sterile 
water. After homogenisation an appropriate dilutions (100 µL) were prepared, 
and inoculated onto non-selective media (Peptone yeast extract glucose agar 
for aerobic and anaerobic counts), and four selective media: MRS-agar for 
Lactobacillus counts, Violet red bile glucose agar and Eosin methylene blue 
agar for Enterobacteriaceae counts, and sulphite agar for sulphite-reducing 
clostridia counts. 
In vitro test for adhesion of L. rhamnosus GG  
Adhesion of L. rhamnosus GG to the intestinal epithelium of the mouse 
was performed using the method of Mäyrä-Mäkinen et al. (1983). The 
standard microscope slides were stained by method for gram-positive and 
gram-negative bacteria identification according to Brown and Brenn (Švob, 
1974). Slides were examined and photographed by light microscope Nikon 
Mikrophot-FXA.  
In vivo adherence ability of  L. rhamnosus GG 
Adherence ability of examined probiotic strain was determined in 
homogenates of large intestine of Swiss albino mice on the 1st and 14th day 
after feeding with L. rhamnosus GG with a daily dose of 2.2ּ1010 viable cells 
for eight consecutive days. Appropriate dilutions of homogenates (100 µl) of 
large intestine were prepared, and inoculated onto non-selective media 
(Peptone yeast extract glucose agar for aerobic and anaerobic counts), and four 
selective media: MRS-agar for Lactobacillus counts, Violet red bile glucose 
agar and Eosin methylene blue agar for Enterobacteriaceae counts, and 
sulphite agar for sulphite-reducing clostridia counts. 
 
 







Immunization of mice with L. rhamnosus GG and determination of  
antibodies by ELISA assay 
The oral immunization was performed eight times over period of eight 
successive days. Each day a mice was given a dose of 2.2ּ1010 viable bacterial 
cells of L. rhamnosus GG in sterile saline solution, by automatic 200 µL 
pipette, directly into the mouth. The control group was challenged with 200 µL 
of sterile saline solution. On the 4th, 8th, 10th, 14th and 21st days, after first 
immunization, the blood samples were collected by bleeding of the tail vein 
directly into the tubes, allowed to clot at room temperature for 3 hours and 
then centrifuged at 3000g for 10 min. The sera samples were kept at -20 oC 
until use. The total and specific anti-lactobacilli (IgA, IgG and IgM) antibodies 
were determined by ELISA (Enzyme-Linked Immunosorbent Assay). 
 
Results and Discussion 
The "BioAktiv LGG" low fat fresh cheese, from LURA d.d., contains 
well-known probiotic strain Lactobacillus rhamnosus GG (LGG). It seams 
reasonable to assume that adequate numbers of the probiotic bacteria need to 
be consumed with probiotic cheese to exert a health-promoting effect for the 
consumer. It has been suggested that, in order to have any therapeutic effect, 
the minimal number of probiotic bacteria in a product should be at 106-108 per 
gram (Kullen and Klaenhammer, 1999). Moreover, it is important that the 
lactobacilli remain viable during refrigerated storage of the product for a 
certain period as fresh cheese may be consumed after storage in the 
refrigerator for several weeks. The results of Schill inger (1999) indicated 
that not all products, available on the market in Germany and other European 
countries, contain probiotic bacteria in high numbers and that not all of them 
show good survival characteristics. L. rhamnosus GG viable counts obtained 
from low fat fresh cheese during 16 days of storage at 4 oC showed high 
numbers (above 108 per gram) even at the end of the storage period and 
therefore survived well in the examined cheese (Fig. 1).  The effect of L. 
rhamnosus GG from this product on the immune response, and its 
survival/residence time in the gastrointestinal tract in Swiss albino mice was 
also examined, as this is an important point in relation to immunomodulation.  
In vitro adhesion ability of L. rhamnosus GG was studied as a prerequisite 
for in vivo adhesion of this strain in Swiss albino mice. Results observed by in 
vitro adhesion test have shown very good adhesive ability of an examined 
strain to intestinal epithelial cells of mice (Fig. 2). These results are in 







agreement with adhesion results observed on the porcine gastric epithelial 
cells, performed by the same method (Mahnet et al. 2002). Survival of L. 
rhamnosus GG during transit trough GI tract of mice was determined in faeces  
 
 
Fig. 1: Survival of Lactobacillus rhamnosus GG in low fat fresh cheese 
"BioAktiv LGG" during storage at 4 oC 
Slika 1: Preživljavanje Lactobacillus rhamnosus GG u svježem posnom siru 
"BioAktiv LGG" tijekom skladištenja pri 4 oC 
A             B 
           
Fig 2:   Adhesion of Lactobacillus rhamnosus GG to the intestinal epithelial 
cells of the mouse. A -  Magnification, x 250; B - Magnification, x 
1000. 
Slika 2: Adhezija stanica Lactobacillus rhamnosus GG na epitelne stanice 
ileuma miša. A – Povećanje, x 250; B – Povećanje, x 1000. 







samples. The number of lactobacilli was increased, and reduction of 
enterobacteria and sulphite-reducing clostridia was observed (Fig 3). These 
results suggested capability of L. rhamnosus GG to survive transit through the 
mouse gastrointestinal tract, and to interact and compete with other  
 
 
Fig. 3:  Comparison of the microbial population in mice faeces before and 
after feeding with Lactobacillus rhamnosus GG. A – aerobic 
bacteria; B – anaerobic bacteria; C – lactic acid bacteria; D – 
Enterobacteriaceae from Violet Red Bile Glucose agar; E – 
Enterobacteriaceae from Eosin Methylene Blue agar; F – sulphite-
reducing clostridia 
Slika 3: Usporedba mikrobne populacije u fecesu miševa prije i nakon 
hranjenja miševa s Lactobacillus rhamnosus GG. A – aerobne 
bakterije; B – anaerobne bakterije; C – bakterije mliječne kiseline; 
Enterobacteriaceae na ljubičasto-crvenom žučnom agaru; E – 
Enterobacteriaceae na eozin metilen plavom agaru; F - sulfito-
reducirajući klostridiji 
microorganisms within the gut environment. In our previous study, L. 
rhamnosus GG from different types of BioAktiv LGG yoghurts, a high degree 
of antimicrobial activity against some enteropathogens, which could influence 
its ability to survive and to adhere in the intestinal tract and operate as an 
effective probiotic by suppressing some harmful bacteria (Mahnet et al. 
2002), was determined. 







In vivo adherence ability of L. rhamnosus GG was determined in 
homogenates of large intestine of Swiss albino mice. The increased number of 
lactobacilli in large intestine, especially one day after feeding with L. 
rhamnosus GG, pointed out the adherence ability of examined probiotic strain. 
The composition of other bacterial strains in the large intestine was also 
strongly influenced by administrated L. rhamnosus GG - the number of 
enterobacteria and sulphite-reducing clostridia was decreased. (Fig. 4). These 
results confirm the good survival and binding of administrated probiotic strain 
to the intestinal epithelial cells. This observation is supported by the results of 
a human study completed by Goldin et al. (1992) where it was demonstrated 
that 60-80 % of individuals consuming L. rhamnosus GG excreted this strain  
 
 
Fig. 4: Microbial counts in large bowel of mice at 1 and 14 days after feeding 
with Lactobacillus rhamnosus GG. A – aerobic bacteria; B – 
anaerobic bacteria; C – lactic acid bacteria; D – Enterobacteriaceae 
from Violet Red Bile Glucose agar; E – Enterobacteriaceae from 
Eosin Methylene Blue agar; F – sulphite-reducing clostridia 
Slika 4: Određivanje broja mikroorganizama u debelom crijevu miševa, 1. i 
14. dan nakon prestanka hranjenja s Lactobacillus rhamnosus GG. A 
– aerobne bakterije; B – anaerobne bakterije; C – bakterije mliječne 
kiseline; D – Enterobacteriaceae na ljubičasto-crvenom žučnom 
agaru; E – Enterobacteriaceae na eozin metilen plavom agaru; F - 
sulfito-reducirajući klostridiji 







for 3-4 days, but only 33 % of the population after 7 days. Therefore, it 
appears likely that daily administration of the preferred strain is necessary for 
maintenance of high probiotic levels. 
Many authors have reported that immunization with lactobacilli can 
stimulate immune response, by production of total and specific serum 
antibodies (Fuller, 1992;1997; Fuller and Perdigon, 2000; Shu, 2003). 
However, the immunomodulatory effect of probiotics is a strain-dependent 
characteristic and species speciality in the host (Perdigón and Pesce de 
Ruiz Holgado, 2000; He et al. 2000). Therefore, a further objective of this 
study was to investigate immunomodulating capacity of L. rhamnosus GG, 
which means induction of antibody production in Swiss albino mice by this 
strain. L. rhamnosus GG slightly stimulates the total immune response, 
demonstrating its positive effect on the host immune system (Figs. 5-7). This 




Fig. 5: Determination of total IgA antibodies in 1:100 diluted sera after oral 
imunization of mice with viable cells of  Lactobacillus rhamnosus GG 
by ELISA method. □  control;  ■  LGG. 
Slika 5: Ukupna IgA antitijela određena u serumima (razrjeđenje 1:100), 
nakon oralne imunizacije miševa sa živim bakterijskim stanicama 












Fig. 6: Determination of total IgG antibodies in  1:100 diluted sera after oral 
imunization of mice with viable cells of  Lactobacillus rhamnosus GG 
by ELISA method. □  control;  ■  LGG. 
Slika 6: Ukupna IgG antitijela određena u serumima (razrjeđenje 1:100), 
nakon oralne imunizacije miševa sa živim bakterijskim stanicama 
Lactobacillus rhamnosus GG, ELISA metodom. □  kontrola;  ■  
LGG. 
This means that specific humoral immune response with examined strains was 
low. The observed total humoral immune enhancement by L. rhamnosus GG 
after oral application in mice could be related to its viability and maintenance 
in the mouse intestine. This statement is supported by the results of Kaila et 
al. (1995). They found out that both, active and inactive forms of L. 
rhamnosus GG have significantly shortened the duration of rotavirus-induced 
diarrhoea. However, only active L. rhamnosus GG cells significantly increases 
the level of specific IgA-secreting cells to rotavirus. Similarly a trend towards 
increased Salmonella specific IgA-levels was found in subjects who received 
combination of L. rhamnosus GG and oral Salmonella vaccination (He et al. 
2000). All these results suggest that, in addition to the beneficial effect related 
to competition in colonization, immuno-enhancing properties of probiotics 
may also be important for protection from infections. 
 








Fig. 7: Determination of total IgM antibodies in 1:100 diluted sera after oral 
imunization of mice with viable cells of  Lactobacillus rhamnosus GG 
by ELISA method. □  control;  ■  LGG. 
Slika 7: Ukupna IgM antitijela određena u serumima (razrjeđenje 1:100), 
nakon oralne imunizacije miševa sa živim bakterijskim stanicama 
Lactobacillus rhamnosus GG, ELISA metodom. □ kontrola;  ■ LGG. 
 
Fig. 8: Determination of anti-lactobacilli IgA antibodies in  1:100 diluted sera 
after oral imunization of mice with viable cells of  Lactobacillus 
rhamnosus GG by ELISA method. □  control;  ■  LGG. 
Slika 8: Specifična anti-laktobacili IgA antitijela određena u serumima 
(razrjeđenje 1:100), nakon oralne imunizacije miševa sa živim 
bakterijskim stanicama Lactobacillus rhamnosus GG, ELISA 
metodom. □  kontrola;  ■  LGG. 








Fig. 9:  Determination of anti-lactobacilli IgG antibodies in  1:100 diluted 
sera after oral imunization of mice with viable cells of  Lactobacillus 
rhamnosus GG by ELISA method. □  control;  ■  LGG. 
Slika 9:  Specifična anti-laktobacili IgG antitijela određena u serumima 
(razrjeđenje 1:100), nakon oralne imunizacije miševa sa živim 
bakterijskim stanicama Lactobacillus rhamnosus GG, ELISA 
metodom. □  kontrola;  ■  LGG. 
 
Fig. 10: Determination of anti-lactobacilli IgM antibodies in  1:100 diluted 
sera after oral imunization of mice with viable cells of  Lactobacillus 
rhamnosus GG by ELISA method. □  control;  ■  LGG. 
Slika 10: Specifična anti-laktobacili IgA antitijela određena u serumima 
(razrjeđenje 1:100), nakon oralne imunizacije miševa sa živim 
bakterijskim stanicama Lactobacillus rhamnosus GG, ELISA 
metodom. □  kontrola;  ■  LGG 








Low fat fresh cheese "BioAktiv LGG" appeared as an attractive carrier for 
probiotic strain L. rhamnosus GG and its viability and probiotic activity. Strain 
L. rhamnosus GG, from low fat fresh cheese "BioAktiv LGG", has the 
capacity to influence the microbial ecology of the host and, by doing so, 
beneficially affect total humoral immune response.  
 
IMUNOMODULACIJSKI UČINAK LACTOBACILLUS 
RHAMNOSUS GG IZ SVJEŽEG POSNOG SIRA " BioAktiv LGG" 
 
Sažetak 
Poticanje imunološkog odgovora probiotičkim mikroorganizmima i njihov 
imunomodulacijski učinak mogu se primijeniti u prevenciji infektivne dijareje, 
sprječavanju hipersenzitivnih reakcija i suzbijanju tumora. Novi probiotički 
proizvod tvrtke LURA d.d., svježi posni sir "BioAktiv LGG", sadrži probiotički 
soj Lactobacillus rhamnosus GG (LGG), koji ima najviše znanstvenih dokaza 
o korisnim učincima na ljudsko zdravlje. Broj živih stanica L. rhamnosus GG 
u svježem posnom siru "BioAktiv LGG" iznosio je 1,3 x 108 CFU/g, i ostao je 
stabilan tijekom 16 dana skladištenja na 4 oC. U ovom radu istražen je utjecaj 
L. rhamnosus GG, izoliranog iz svježeg posnog sira "BioAktiv LGG", na 
imuno odgovor, te njegovo preživljavanje/zadržavanje u probavnom sustavu 
Swiss albino miševa, kao važan preduvjet za imunomodulacijsko djelovanje. 
Tijekom hranjenja miševa s 2,2 x 1010 stanica L. rhamnosus GG dnevno, 
povećao se ukupan broj laktobacila, a smanjio broj enterobakterija i sulfito-
reducirajućih klostridija u fecesima miševa. Sličan rezultat dobiven je 
određivanjem sastava crijevne mikroflore u homogenatima tankog i debelog 
crijeva miševa, prvi i četrnaesti dan nakon prestanka hranjenja miševa s L. 
rhamnosus GG, što ukazuje na adhezijska svojstva ispitivanog probiotičkog 
soja. Također je provedena i oralna imunizacija Swiss albino miševa, s 
dnevnom dozom od 2,2 x 1010 stanica L. rhamnosus GG kroz period od 8 
dana. Uzorci krvi Swiss albino miševa sakupljani su 4., 8., 10., 14., 17. i 21. 
dana nakon prve imunizacije. U priređenim serumima određivana su ukupna i 
specifična anti-laktobacili IgA, IgG i IgM antitijela, ELISA metodom. L. 
rhamnosus GG stimulirao je ukupni humoralni imuno odgovor, a nije izazvao 
specifični imuno odgovor, što potvrđuje njegov imunomodulacijski učinak, i 







čini novi probiotički proizvod, svježi posni sir "BioAktiv LGG", dobrim 
matriksom za ispitivani probiotički soj. 
Ključne riječi: Lactobacillus rhamnosus, probiotička svojstva, adhezija, 
imunomodulacija, antitijela, ELISA 
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